首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of viral hepatitis

缩写:J VIRAL HEPATITIS

ISSN:1352-0504

e-ISSN:1365-2893

IF/分区:2.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引2784条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
L Sandmann,L Windzio,B Bremer et al. L Sandmann et al.
Reliable quantification of hepatitis D virus (HDV) RNA levels is necessary for initiating and guiding antiviral treatment. The aim of this work is to develop and validate a digital PCR method for the accurate quantification of HDV RNA, incl...
Grishma Hirode,Mai Kilany,Steven Pi et al. Grishma Hirode et al.
Nucleos(t)ide analogs (NAs) provide prolonged viral suppression with favourable clinical outcomes in chronic hepatitis B (CHB) patients. Characterisation of adverse hepatic events after NA cessation leading to liver transplantation (LT) is ...
Speranta Iacob,Mirela Chitul,Diana Stan et al. Speranta Iacob et al.
Given that delta hepatitis is associated with a 2-6 times higher risk for hepatocellular carcinoma (HCC) compared to HBV monoinfection, we aimed to identify the negative prognostic factors for complications associated with HDV infection (pa...
Yu Peng,Yuxin Song,Xin Liu et al. Yu Peng et al.
Hepatitis B virus (HBV) is the primary etiological agent of chronic hepatitis B (CHB) infection, posing a serious threat to human health. The pregenomic RNA (pgRNA) of HBV is the template for HBV reverse transcription, and the epsilon stem-...
Elizabeth M Marlowe,Brooke E Swanson,Susan E Realegeno et al. Elizabeth M Marlowe et al.
Hepatitis D virus (HDV) affects nearly 5% of people globally who are chronically infected with hepatitis B virus, according to the World Health Organisation. The prevalence of HDV in the United States is considered lower than in other count...
Shifu Li,Wenbin Dong,Yingni Yu et al. Shifu Li et al.
Diagnosed but untreated (DBU) hepatitis C virus (HCV) infected patients are a key group for HCV elimination efforts. This study aims to pilot a government-led, multi-sectoral approach to universal patient recall and treatment mobilisation i...
Ngai Sze Wong,Denise Pui-Chung Chan,Grace Lai-Hung Wong et al. Ngai Sze Wong et al.
In the setting of high hepatitis B virus (HBV) endemicity, we studied the cost-effectiveness of universal HBV screen-and-treat strategies for averting HBV-related morbidity and mortality in Hong Kong, where diagnosis and treatment coverages...
Xinwei Wang,Xipeng Yan,Baoren He et al. Xinwei Wang et al.
Acute hepatitis C (AHC) represents a considerable challenge to global public health, although direct-acting antiviral (DAA) therapy has substantially improved therapeutic outcomes for hepatitis C virus infection. Data were exclusively obtai...
Annabel A Powell,Annastella Costella,Rachel Roche et al. Annabel A Powell et al.
The United Kingdom, along with many other countries, is working towards eliminating viral hepatitis as a public health threat by 2030, with a combined mortality target of less than or equal to six deaths per 100,000 population. The current ...
Jiajun Sun,Matthew Kelly,Tsheten Tsheten et al. Jiajun Sun et al.
The World Health Organisation has targeted the Hepatitis C virus (HCV) to be eliminated as a public health threat by 2030. Equitable access to HCV testing and treatment services is important in achieving this goal. Migrants often face barri...